News

Abcell-bio Secures CIR Agreement from French Ministry: Offering Enhanced Access to Cord Blood Cells and Tax Benefits for R&D Partners

Abcell-bio arose from the will to accompany research by facilitating the access to primary resources which are difficult to get, especially cells from cord blood.

With a strong and unique network of French maternities and a robust production process, Abcell-bio also develops a Research & Development activity to face the challenges of the upcoming research.

Did you say Red September?

Every year, we hear about Pink October and Movember, but Red September isn’t as widely recognized. This month is dedicated to raising awareness for blood cancers, which affect 45,000 individuals annually in France. ‘Live with a MPN’, a patient association, launched this initiative last year and is now rolling out its second edition.

Humanized mice using CD34+ from cord blood for investigating malaria parasite

This article describe a new humanized mice model that is a unique tool for investigating, in vivo, the biology of Plasmodium vivax, the most widespread human malaria parasite. This new model of humanized mice using CD34+ cells from cord blood (purchased from Abcell-bio company), allows a reconstitution of the human erythropoiesis.